Methimazole and Subdural haematoma - a phase IV clinical study of FDA data

Summary:

Subdural haematoma is reported as a side effect among people who take Methimazole (methimazole), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Xarelto, and have Atrial fibrillation/flutter.

The phase IV clinical study analyzes which people have Subdural haematoma when taking Methimazole. It is created by eHealthMe based on reports of 7,420 people who have side effects when taking Methimazole from the FDA, and is updated regularly.

What is Methimazole?

Methimazole has active ingredients of methimazole. It is often used in hyperthyroidism. eHealthMe is studying from 8,016 Methimazole users. Check the latest studies of Methimazole.

What is Subdural haematoma?

Subdural haematoma (blood collects between the skull and the surface of the brain) is found to be associated with 999 drugs and 1,084 conditions by eHealthMe. Check the latest studies of Subdural haematoma.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

7,420 people reported to have side effects when taking Methimazole.
Among them, 12 people (0.16%) have Subdural haematoma.

Could Methimazole cause Subdural haematoma?

Among these 12 people:

How long have people been on Methimazole when they have Subdural haematoma? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Subdural haematoma when taking Methimazole? *

  • female: 50 %
  • male: 50 %

What is the age of people who have Subdural haematoma when taking Methimazole? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

What are other drugs people take besides Methimazole? *

  1. Xarelto: 4 people, 33.33%
  2. Pantoprazole: 3 people, 25.00%
  3. Revatio: 3 people, 25.00%
  4. Torsemide: 3 people, 25.00%
  5. Metoprolol Succinate: 2 people, 16.67%
  6. Bisoprolol Fumarate: 2 people, 16.67%
  7. Plavix: 2 people, 16.67%
  8. Pradaxa: 2 people, 16.67%
  9. Baby Aspirin: 2 people, 16.67%
  10. Lorazepam: 2 people, 16.67%

What are other side effects people have besides Subdural haematoma? *

  1. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 25.00%
  2. Weakness: 2 people, 16.67%
  3. Cerebral Haematoma (collection of blood in brain): 2 people, 16.67%
  4. Hernia (hernia happens when part of an internal organ or tissue bulges through a weak area of muscle): 2 people, 16.67%
  5. Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 2 people, 16.67%
  6. Chronic Kidney Disease: 2 people, 16.67%
  7. Gait Disturbance: 2 people, 16.67%
  8. Atrioventricular Block Complete (heart block complete): 2 people, 16.67%
  9. Pneumonia: 2 people, 16.67%
  10. Pulmonary Hypertension (increase in blood pressure in the lung artery): 2 people, 16.67%

What are the existing conditions these people have? *

  1. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 6 people, 50.00%
  2. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 16.67%
  3. Reversible Ischaemic Neurological Deficit (transient stroke resulting from a decrease in cerebral blood flow): 2 people, 16.67%
  4. Cardiac Failure Congestive: 2 people, 16.67%
  5. Anaemia (lack of blood): 2 people, 16.67%
  6. Thrombosis (formation of a blood clot inside a blood vessel): 1 person, 8.33%
  7. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 8.33%
  8. Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 8.33%
  9. Lung Disorder (lung disease): 1 person, 8.33%
  10. Hepatocellular Carcinoma (liver cancer): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Methimazole and have Subdural haematoma?

- Check whether Subdural haematoma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Methimazole:

Subdural haematoma treatments and more:

How severe was Subdural haematoma and when was it recovered:

Expand to all the drugs that have ingredients of methimazole:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methimazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Subdural haematoma:

Browse all the conditions that are associated with Subdural haematoma:


How the study uses the data?

The study uses data from the FDA. It is based on methimazole (the active ingredients of Methimazole) and Methimazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: